# WuXi Biologics starts construction of biologics facility in Dundalk, Ireland

WuXi Biologics commenced construction of a new biologics drug substance manufacturing facility in Dundalk, Ireland. The facility will have a total capacity of 48,000L fed-batch and 6,000L perfusion using single-use bioreactors.

- Type: New facility
- Announced: 2018-12-05
- Where: Mullagharlin, Dundalk, Co. Louth, Ireland
- Status: under construction
- Capacity: 48,000L fed-batch and 6,000L perfusion
- Products: biologics drug substance
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [WuXi Biologics](https://endata.com/companies/31607.md)

## Sources

- [nai500.com](https://nai500.com/blog/2018/12/wuxi-biologics-commenced-construction-of-the-largest-biomanufacturing-facility-using-single-use-bioreactors-in-ireland/), 2018-12-06: "We are excited to witness the construction of WuXi Biologics’ first global site today"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.